Latest articles

Optimising pharmacological management of HbA1c levels in patients with type 2 diabetes: from metformin to insulin

A variety of subsidised medicines are available to help manage...

May 2019

Emerging issues in the management of chlamydia and gonorrhoea

New evidence suggests that a seven-day course of doxycycline...

April 2019

Mycoplasma genitalium: considerations for testing and treatment in primary care

Mycoplasma genitalium infection is a potential cause of urethritis...

April 2019

Syphilis rates continue to rise

New Zealand is in the midst of a syphilis epidemic. Men who...

April 2019

HIV Pre-Exposure Prophylaxis (PrEP): a how-to guide

Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis...

April 2019

HPV vaccination: getting the programme back on track

Vaccination against human papillomavirus (HPV) infection provides...

March 2019

Prescribing report: Proton pump inhibitor prescribing in primary care

This report provides prescribers with data about the patients...

March 2019

Older people’s health theme: Frailty and deprescribing

The following questions can be used as discussion points for...

March 2019

Advice on measles vaccination from the Ministry of Health 14/3/19

Canterbury DHB are undertaking a MMR vaccination campaign in...

March 2019

Contraception: which option for which patient?

Prescribing contraception is a core part of primary care practice....

March 2019

Condoms: advising on the options

Condoms are the only form of contraception that protects against...

March 2019

Oral contraceptives: selecting a pill

Oral contraceptive pills are a safe and effective contraceptive...

March 2019

Depot medroxyprogesterone acetate (DMPA) injections: an intermediate option

Depot medroxyprogesterone acetate injections are a form of hormonal...

March 2019

Long-acting contraceptives: implants and IUDs

Long-acting contraceptives include progestogen (levonorgestrel)...

March 2019

Prescribing for a trial period: when and how?

When initiating or changing the dose of a medicine, simple changes...

February 2019

Managing constipation in older people

Constipation is common in older people due to factors such as...

February 2019

Hepatitis C management in primary care has changed

A new direct-acting antiviral (DAA) oral regimen for the treatment...

January 2019

Testing for hepatitis C virus (HCV) in patients at high risk of infection

Hepatitis C infection occurs through exposure to infected blood...

January 2019

Pre-treatment assessment for patients with chronic HCV infection

Patients should be assessed for cirrhosis via clinical examination,...

January 2019

Management and follow-up of patients prescribed glecaprevir + pibrentasvir

Glecaprevir + pibrentasvir is taken once daily for eight weeks....

January 2019

Hepatitis C is now curable:
contributed by Dr Tony Farrell

Dr Tony Farrell is a general practitioner in Mount Maunganui...

January 2019

Stopping proton pump inhibitors in older people

Over one-third of people aged 65 years and older in New Zealand...

January 2019

Bisphosphonates: addressing the duration conundrum

Bisphosphonates accumulate within bone tissue where they help...

January 2019

Clinical Audit: Identifying patients who may benefit from “stepping down” PPI treatment

This audit identifies patients who are prescribed the proton...

January 2019

Managing patients taking anticoagulants and antiplatelets prior to minor procedures and surgery

December 2018

2018 Annual Prescribing Report

This report provides you with an opportunity to reflect on your...

December 2018

Substance use disorder theme: Unintentional misuse of prescription medicines - Peer Group Discussion for Prescribers

The following questions can be used as discussion points for...

December 2018

Substance use disorder theme: Unintentional misuse of prescription medicines - Peer Group Discussion for Pharmacists

The following questions can be used as discussion points for...

December 2018

Stopping medicines in older people: the flip side of the prescribing equation

Older people are generally prescribed more medicines than younger...

December 2018

Frailty in older people: a discussion

The concept of frailty identifies vulnerable people who have...

November 2018

Cardiovascular disease risk assessment in primary care: the role of aspirin

In February 2018, the Ministry of Health released the Cardiovascular...

November 2018

Assessment and management of alcohol misuse by primary care

Recent evidence shows that levels of alcohol consumption that...

November 2018

Addressing methamphetamine use in primary care

Methamphetamine, commonly referred to in New Zealand as “meth”...

November 2018

Cardiovascular disease risk assessment in primary care: managing lipids

The Cardiovascular Disease Risk Assessment and Management for...

October 2018

Unintentional misuse of prescription medicines

There is a significant issue in the community with people taking...

October 2018

Understanding the role of opioids in chronic non-malignant pain

There is no evidence that opioids such as tramadol are effective...

October 2018

Balancing the benefits and risks of prescribing antiepileptic medicines in women

Antiepileptic medicines reduce the risk of seizures in people...

October 2018

Prescribing hypnotic medicines: a focus on zopiclone

Key practice points
• Zopiclone is the most frequently prescribed...

October 2018

Vildagliptin: a new treatment for type 2 diabetes

Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor available...

September 2018

NZF is changing the way that pregnancy and breast-feeding advice for medicines is presented

From 1 October, 2018, the New Zealand Formulary (NZF) will replace...

September 2018

Hereditary diffuse gastric cancer: an overview for primary care

Hereditary diffuse gastric cancer makes up around 1% of stomach...

September 2018

Prescribing ACE inhibitors: time to reconsider old habits

Prescribers in New Zealand are highly reliant on cilazapril...

September 2018

Smoke and mirrors: is vaping useful for smokers who cannot quit?

There are many approved and fully subsidised medicines that...

August 2018

Cardiovascular disease risk assessment in primary care: managing blood pressure

The recently released Cardiovascular Disease Risk Assessment...

August 2018

Hepatitis B: treatments now available for primary care

Tenofovir disoproxil and entecavir are once daily oral antiviral...

August 2018

Guidelines for testing, perioperative and bleeding management for dabigatran and rivaroxaban

These guidelines have been produced by PHARMAC in conjunction...

July 2018

Rivaroxaban: a fully-subsidised oral anticoagulant

From 1 August, 2018, rivaroxaban will be fully subsidised without...

July 2018

Prescribing topical medicines for skin infection - An update

This report provides an update on the use and monitoring of...

July 2018

Topical antibiotics: keep reducing use

Encouraging progress has been made by prescribers in New Zealand...

July 2018

Managing winter illnesses without antibiotics - Clinical Audit

This audit identifies patients who present with winter illnesses...

July 2018

Trends in primary care theme: Gout

The following questions can be used as discussion points for...

June 2018

Sepsis: recognition, diagnosis and early management

June 2018

Cold season: managing without antibiotics

For the majority of people with upper respiratory tract infections...

June 2018

Antibiotics: the future is short

In general, the recommended durations of antibiotic treatment...

June 2018

Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

From 1 June, 2018, aripiprazole can be prescribed without Special...

June 2018

Made with by the bpacnz team